pazopanib 200 MG Oral Tablet [Votrient]
- RxCUI
- 867506
- RxNorm name
- pazopanib 200 MG Oral Tablet [Votrient]
- Display name
- pazopanib 200 MG Oral Tablet [Votrient]
- Full name
- pazopanib 200 MG Oral Tablet [Votrient]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:27
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VOTRIENT | PAZOPANIB HYDROCHLORIDE | Novartis Pharmaceuticals Corporation | eeaaaf38-fb86-4d9f-a19d-0f61daac2fd7 | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | 867506 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| eeaaaf38-fb86-4d9f-a19d-0f61daac2fd7 | pazopanib 200 MG Oral Tablet [Votrient] | SBD | 15 | These highlights do not include all the information needed to use VOTRIENT safely and effectively. See full prescribing information for VOTRIENT. VOTRIENT ® (pazopanib) tablets, for oral use Initial U.S. Approval: 2009 | 20251216 |
| eeaaaf38-fb86-4d9f-a19d-0f61daac2fd7 | Votrient 200 MG Oral Tablet | SY | 15 | These highlights do not include all the information needed to use VOTRIENT safely and effectively. See full prescribing information for VOTRIENT. VOTRIENT ® (pazopanib) tablets, for oral use Initial U.S. Approval: 2009 | 20251216 |
| eeaaaf38-fb86-4d9f-a19d-0f61daac2fd7 | Votrient 200 MG Oral Tablet | PSN | 15 | These highlights do not include all the information needed to use VOTRIENT safely and effectively. See full prescribing information for VOTRIENT. VOTRIENT ® (pazopanib) tablets, for oral use Initial U.S. Approval: 2009 | 20251216 |